Edward P. Gelmann, MD

After becoming an established researcher at the NCI through his work in the molecular biology of solid tumors, Dr. Gelmann moved to Georgetown University where he assumed the role of chief of the Division of Hematology/Oncology. He then headed to Columbia University, where he served as chief of the Division of Hematology/Oncology and then deputy director of the cancer center. He continues his research on the molecular biology of prostate cancer. His laboratory has made major contributions to understanding of the genetic steps that transform a normal prostate cell to a cancer cell.
Dr. Gelmann also remains actively involved in oncology patient care, in pre- and postdoctoral education, and in teaching graduate students, house staff and fellows.
Dr. Gelmann serves as Editor-in-Chief of the journal Endocrine Oncology.
Degree(s)
- MD: Stanford University School of Medicine, Palo Alto, California, 1972-76
- BS (magna cum laude): Yale University, New Haven, Connecticut, 1968-72
molecular biology of prostate cancer